DJIA 17,938.59 133.79 0.75%
NASDAQ 4,780.14 14.76 0.31%
S&P 500 2,077.04 6.39 0.31%
market minute promo

Amarin Corp plc (ADR) (NASDAQ: AMRN)

1.06 -0.07 (-6.19%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AMRN $1.06 -6.19%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.13
Previous Close $1.13
Daily Range $1.06 - $1.19
52-Week Range $0.78 - $2.75
Market Cap $185.1M
P/E Ratio -2.22
Dividend (Yield) $0.00 (0.0%)
Volume 1,133,973
Average Daily Volume 1,992,440
Current FY EPS -$0.47

Sector

Healthcare

Industry

Drugs

Amarin Corp plc (ADR) (AMRN) Description

The Company is engaged in the research, development and commercialization of novel drugs for the treatment of central nervous system disorders. Website: http://www.amarincorp.com/

News & Commentary Rss Feed

Why Amarin Corporation PLC Stock Flew 37% Higher in November

Amarin shares rocket higher in November after the company released exciting new data on Vascepa. But will it be enough to sustain the rally more than a few weeks?

Good News: Vascepa Kept Its Place On National Formularies

Amarin Corporation: Upside Becomes Clearer While The Path To The Finish Line Remains Murky

Amarin: The Silence Of The Lamb

Update: Amarin Earnings Show It Blew Its Chance At 2014 Profitability

Amarin Corporation plc (AMRN) in Focus: Stock Soars 23.4% - Tale of the Tape

Biotech Stock Mailbag: Spectrum, Intercept, Orexigen, Amarin, MannKind

Update: Amarin's Q3 2014 Earnings Report

Amarin's Value With Or Without REDUCE-IT And A Final Word On Management

Update: Amarin Announces Its Q3 2014 Cash Balance

See More AMRN News...

AMRN's Top Competitors

AMRN $1.06 (-6.19%)
Current stock: AMRN
JNJ $106.68 (1.07%)
Current stock: JNJ
NVS $95.25 (0.68%)
Current stock: NVS
RHHBY $34.69 (0.64%)
Current stock: RHHBY